Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-25-000329
Filing Date
2025-05-14
Accepted
2025-05-14 16:04:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13034
2 ex991.htm EX-99.1 AGREEMENT 4421
  Complete submission text file 0000935836-25-000329.txt   19148
Mailing Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703
Business Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 25945238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)